Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Protagonist Therapeutics, Inc | Director | Common Stock | 28K | $885K | $31.62 | Mar 7, 2024 | Direct |
Molecular Templates, Inc. | Director | Stock Option (right to buy) | 1K | Oct 27, 2023 | Direct | ||
Protagonist Therapeutics, Inc | Director | Stock Option (right to buy) | 0 | Mar 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PTGX | Protagonist Therapeutics, Inc | Mar 7, 2024 | 2 | $12.3K | 4 | Mar 11, 2024 | Director |
PTGX | Protagonist Therapeutics, Inc | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
MTEM | Molecular Templates, Inc. | Oct 27, 2023 | 1 | $0 | 4 | Oct 31, 2023 | Director |
PTGX | Protagonist Therapeutics, Inc | Apr 10, 2023 | 2 | $5.39K | 4 | Apr 11, 2023 | Director |
PTGX | Protagonist Therapeutics, Inc | Jan 16, 2023 | 1 | $0 | 4 | Jan 18, 2023 | Director |
MTEM | Molecular Templates, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director |
PTGX | Protagonist Therapeutics, Inc | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
MTEM | Molecular Templates, Inc. | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |
PTGX | Protagonist Therapeutics, Inc | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |